Andrographolide and analogues as inhibitors of TNFα and IL-1β expression
US7625945B2 · kind B2 · utility
4Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2005 |
| Grant date | Dec 1, 2009 |
| Priority date | — |
| Expiry date | May 26, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method of inhibiting the expression of TNFα or IL-1β with a compound of the following formula:wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.